Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Differentiating the cellular and humoral components of neuromuscular blocking agent-induced anaphylactic reactions in patients undergoing anaesthesia.

Aalberse RC, Kleine Budde I, Mulder M, Stapel SO, Paulij W, Leynadier F, Hollmann MW.

Br J Anaesth. 2011 May;106(5):665-74. doi: 10.1093/bja/aer028. Epub 2011 Mar 17.

2.

Comparison of analytical methods to detect instability of etanercept during thermal stress testing.

Maarschalkerweerd Av, Wolbink GJ, Stapel SO, Jiskoot W, Hawe A.

Eur J Pharm Biopharm. 2011 Jun;78(2):213-21. doi: 10.1016/j.ejpb.2011.01.012. Epub 2011 Jan 24.

PMID:
21272639
3.

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept.

Jamnitski A, Bartelds GM, Nurmohamed MT, van Schouwenburg PA, van Schaardenburg D, Stapel SO, Dijkmans BA, Aarden L, Wolbink GJ.

Ann Rheum Dis. 2011 Feb;70(2):284-8. doi: 10.1136/ard.2010.135111. Epub 2010 Nov 10.

PMID:
21068090
4.

Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis.

van Kuijk AW, de Groot M, Stapel SO, Dijkmans BA, Wolbink GJ, Tak PP.

Ann Rheum Dis. 2010 Mar;69(3):624-5. doi: 10.1136/ard.2009.108787. No abstract available.

PMID:
20223840
5.

Anti-epoetin-antibody-induced anemia in a child with chronic renal failure.

Jöbsis JJ, Fijnvandraat K, Stapel SO, Bouts AH.

Pediatr Nephrol. 2010 May;25(5):993-4. doi: 10.1007/s00467-010-1442-0. Epub 2010 Feb 18. No abstract available.

6.

Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.

Lecluse LL, Driessen RJ, Spuls PI, de Jong EM, Stapel SO, van Doorn MB, Bos JD, Wolbink GJ.

Arch Dermatol. 2010 Feb;146(2):127-32. doi: 10.1001/archdermatol.2009.347.

PMID:
20157022
7.

A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.

van den Bemt BJ, Vos K, den Broeder AA, Blom M, Thurlings RM, Bartelds GM, Stapel SO, Barrera P, Tak PP, Nurmohamed MT, Wolbink GJ.

Ann Rheum Dis. 2009 Aug;68(8):1368-9. doi: 10.1136/ard.2008.095448. No abstract available.

PMID:
19605744
8.

Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.

Thurlings RM, Teng O, Vos K, Gerlag DM, Aarden L, Stapel SO, van Laar JM, Tak PP, Wolbink GJ.

Ann Rheum Dis. 2010 Feb;69(2):409-12. doi: 10.1136/ard.2009.109041. Epub 2009 Jul 12.

PMID:
19596693
9.

Immunoglobulin G4: an odd antibody.

Aalberse RC, Stapel SO, Schuurman J, Rispens T.

Clin Exp Allergy. 2009 Apr;39(4):469-77. doi: 10.1111/j.1365-2222.2009.03207.x. Epub 2009 Feb 13. Review.

PMID:
19222496
10.

Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report.

Stapel SO, Asero R, Ballmer-Weber BK, Knol EF, Strobel S, Vieths S, Kleine-Tebbe J; EAACI Task Force.

Allergy. 2008 Jul;63(7):793-6. doi: 10.1111/j.1398-9995.2008.01705.x. Epub 2008 May 16.

PMID:
18489614
11.

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis.

de Vries MK, van der Horst-Bruinsma IE, Nurmohamed MT, Aarden LA, Stapel SO, Peters MJ, van Denderen JC, Dijkmans BA, Wolbink GJ.

Ann Rheum Dis. 2009 Apr;68(4):531-5. doi: 10.1136/ard.2008.089979. Epub 2008 Mar 28.

PMID:
18375542
12.

Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation.

de Vries MK, Wolbink GJ, Stapel SO, de Vrieze H, van Denderen JC, Dijkmans BA, Aarden LA, van der Horst-Bruinsma IE.

Ann Rheum Dis. 2007 Sep;66(9):1252-4. Epub 2007 May 1.

13.

Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation.

de Vries MK, Wolbink GJ, Stapel SO, de Groot ER, Dijkmans BA, Aarden LA, van der Horst-Bruinsma IE.

Ann Rheum Dis. 2007 Jan;66(1):133-4. No abstract available.

14.

Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.

Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis CA, Maillere B, Kay AB, Larché M.

Clin Exp Allergy. 2006 Apr;36(4):465-74.

PMID:
16630151
15.

Immunoglobulin E and G4 antibody responses in occupational airway exposure to bovine and porcine plasma proteins.

Krop EJ, Stapel SO, De Vrieze H, Van der Zee JS.

Int Arch Allergy Immunol. 2006;139(3):237-44. Epub 2006 Jan 27.

PMID:
16446546
16.

Coughing in pre-school children in general practice: when are RAST's for inhalation allergy indicated?

Eysink PE, Bottema BJ, ter Riet G, Aalberse RC, Stapel SO, Bindels PJ.

Pediatr Allergy Immunol. 2004 Oct;15(5):394-400.

PMID:
15482513
17.

IgE testing in capillary blood.

Stapel SO, Eysink PE, Vrieze J, Aalberse RC.

Pediatr Allergy Immunol. 2004 Jun;15(3):230-3.

PMID:
15209955
18.

IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.

Wensing M, Akkerdaas JH, van Leeuwen WA, Stapel SO, Bruijnzeel-Koomen CA, Aalberse RC, Bast BJ, Knulst AC, van Ree R.

J Allergy Clin Immunol. 2002 Sep;110(3):435-42.

PMID:
12209091
19.

Do levels of immunoglobulin G antibodies to foods predict the development of immunoglobulin E antibodies to cat, dog and/or mite?

Eysink PE, Bindels PJ, Stapel SO, Bottema BJ, Van Der Zee JS, Aalberse RC.

Clin Exp Allergy. 2002 Apr;32(4):556-62.

PMID:
11972602
20.

Inadvertent BSA-induced elution of IgE in the BSA-RAST.

Kleine Budde I, de Heer PG, Stapel SO, van der Zee JS, Aalberse RC.

Allergy. 2001 Nov;56(11):1055-60.

PMID:
11703218
21.

Structure of food allergens in relation to allergenicity.

Aalberse RC, Stapel SO.

Pediatr Allergy Immunol. 2001;12 Suppl 14:10-4. Review. No abstract available.

PMID:
11380891
22.

Structural aspects of cross-reactivity and its relation to antibody affinity.

Aalberse RC, Kleine Budde I, Stapel SO, van Ree R.

Allergy. 2001;56 Suppl 67:27-9. Review.

PMID:
11298003
23.

An IL-13 promoter polymorphism associated with increased risk of allergic asthma.

van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, Stapel SO, Bakker A, Verweij CL, Aarden LA, van der Zee JS.

Genes Immun. 1999 Sep;1(1):61-5.

24.

Outbreak of occupational allergic asthma in a Stephanotis floribunda nursery.

van der Zee JS, de Jager KS, Kuipers BF, Stapel SO.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):950-2. No abstract available.

PMID:
10329834
25.

Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a cross-sectional study.

Eysink PE, De Jong MH, Bindels PJ, Scharp-Van Der Linden VT, De Groot CJ, Stapel SO, Aalberse RC.

Clin Exp Allergy. 1999 May;29(5):604-10.

PMID:
10231319
26.

Standardization of in vivo and in vitro diagnostic procedures in food allergy.

Aalberse RC, Stapel SO, van Ree R.

Allergy. 1998;53(46 Suppl):62-4.

PMID:
9826002
27.

Allergy to bumblebee venom. II. IgE cross-reactivity between bumblebee and honeybee venom.

Stapel SO, Waanders-Lijster de Raadt J, van Toorenenbergen AW, de Groot H.

Allergy. 1998 Aug;53(8):769-77.

PMID:
9722226
28.

Cross-reactivity between buckwheat and latex.

De Maat-Bleeker F, Stapel SO.

Allergy. 1998 May;53(5):538-9. No abstract available.

PMID:
9636816
29.

The role of IL-13 in IgE synthesis by allergic asthma patients.

Van der Pouw Kraan TC, Van der Zee JS, Boeije LC, De Groot ER, Stapel SO, Aarden LA.

Clin Exp Immunol. 1998 Jan;111(1):129-35.

30.

Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma.

van der Pouw Kraan TC, Boeije LC, de Groot ER, Stapel SO, Snijders A, Kapsenberg ML, van der Zee JS, Aarden LA.

J Immunol. 1997 Jun 1;158(11):5560-5.

PMID:
9164981
31.

Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy.

Van Ree R, Van Leeuwen WA, Dieges PH, Van Wijk RG, De Jong N, Brewczyski PZ, Kroon AM, Schilte PP, Tan KY, Simon-Licht IF, Roberts AM, Stapel SO, Aalberse RC.

Clin Exp Allergy. 1997 Jan;27(1):68-74.

PMID:
9117883
32.

Juvenile chronic arthritis and coeliac disease in The Netherlands.

George EK, Hertzberger-ten Cate R, van Suijlekom-Smit LW, von Blomberg BM, Stapel SO, van Elburg RM, Mearin ML.

Clin Exp Rheumatol. 1996 Sep-Oct;14(5):571-5.

PMID:
8913663
33.

Screening for coeliac disease in Dutch children with associated diseases.

George EK, Mearin ML, Bouquet J, von Blomberg BM, Stapel SO, van Elburg RM, de Graaf EA, Hertzberger-ten Cate R, van Suijlekom-Smith LW, Reeser HM, Oostdijk W.

Acta Paediatr Suppl. 1996 May;412:52-3.

PMID:
8783759
34.

Fel d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests.

Witteman AM, Stapel SO, Sjamsoedin DH, Jansen HM, Aalberse RC, van der Zee JS.

Int Arch Allergy Immunol. 1996 Apr;109(4):369-75.

PMID:
8634522
35.

High frequency of celiac disease in Down syndrome.

George EK, Mearin ML, Bouquet J, von Blomberg BM, Stapel SO, van Elburg RM, de Graaf EA.

J Pediatr. 1996 Apr;128(4):555-7.

PMID:
8618192
36.

The relationship between RAST and skin test results in patients with asthma or rhinitis: a quantitative study with purified major allergens.

Witteman AM, Stapel SO, Perdok GJ, Sjamsoedin DH, Jansen HM, Aalberse RC, van der Zee JS.

J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):16-25.

PMID:
8568133
37.

The decay of house dust mite allergens, Der p I and Der p II, under natural conditions.

de Boer R, van der Hoeven WA, Stapel SO.

Clin Exp Allergy. 1995 Aug;25(8):765-70.

PMID:
7584689
38.

Grass pollen immunotherapy induces highly cross-reactive IgG antibodies to group V allergen from different grass species.

van Ree R, Brewczyński PZ, Tan KY, Mulder-Willems HJ, Widjaja P, Stapel SO, Aalberse RC, Kroon AM.

Allergy. 1995 Mar;50(3):281-3.

PMID:
7677246
39.

Multiplicity of cross-reactive epitopes on Bet v I as detected with monoclonal antibodies and human IgE.

Akkerdaas JH, van Ree R, Aalbers M, Stapel SO, Aalberse RC.

Allergy. 1995 Mar;50(3):215-20.

PMID:
7545879
40.

Allergen-specific IgG4 in atopic disease.

Aalberse RC, Van Milligen F, Tan KY, Stapel SO.

Allergy. 1993 Nov;48(8):559-69. Review. No abstract available.

PMID:
8116855
41.

Human proteins in house dust.

Witteman AM, van Leeuwen J, Perdok GJ, van der Zee JS, Stapel SO, Aalberse RC.

Allergy. 1993 Jul;48(5):383-4. No abstract available.

PMID:
8368467
42.

'Horoscope effect' not only for seasonal but also for non-seasonal allergens.

Aalberse RC, Nieuwenhuys EJ, Hey M, Stapel SO.

Clin Exp Allergy. 1992 Nov;22(11):1003-6.

PMID:
1468027
43.

Variability of crossreactivity of IgE antibodies to group I and V allergens in eight grass pollen species.

Van Ree R, Driessen MN, Van Leeuwen WA, Stapel SO, Aalberse RC.

Clin Exp Allergy. 1992 Jun;22(6):611-7.

PMID:
1382820
44.

Statistical analysis of IgE antibodies to the common inhalant allergens in 44,496 sera.

de Groot H, Stapel SO, Aalberse RC.

Ann Allergy. 1990 Aug;65(2):97-104.

PMID:
2382879
45.

Reverse-sandwich ELISA may underestimate antibody titers.

van Ree R, Stapel SO, Aalberse RC.

J Allergy Clin Immunol. 1989 Oct;84(4 Pt 1):562-4. No abstract available.

PMID:
2794298
46.

Characterization with monoclonal and polyclonal antibodies of a new major allergen from grass pollen in the group I molecular weight range.

van Ree R, Clemens JG, Aalbers M, Stapel SO, Aalberse RC.

J Allergy Clin Immunol. 1989 Jan;83(1):144-51.

PMID:
2913133
47.

Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein.

Wistow GJ, Lietman T, Williams LA, Stapel SO, de Jong WW, Horwitz J, Piatigorsky J.

J Cell Biol. 1988 Dec;107(6 Pt 2):2729-36.

48.

Scl-86, a marker antigen for diffuse scleroderma.

van Venrooij WJ, Stapel SO, Houben H, Habets WJ, Kallenberg CG, Penner E, van de Putte LB.

J Clin Invest. 1985 Mar;75(3):1053-60.

49.

epsilon-Crystallin, a novel avian and reptilian eye lens protein.

Stapel SO, Zweers A, Dodemont HJ, Kan JH, de Jong WW.

Eur J Biochem. 1985 Feb 15;147(1):129-36.

50.

Ratites as oldest offshoot of avian stem--evidence from alpha-crystallin A sequences.

Stapel SO, Leunissen JA, Versteeg M, Wattel J, de Jong WW.

Nature. 1984 Sep 20-26;311(5983):257-9.

PMID:
6482951

Supplemental Content

Loading ...
Support Center